SIRT7 and metastatic neoplasm: In epithelialprostate carcinomas, high SIRT7 levels are associated with aggressive cancerphenotypes, metastatic disease, and poor patient prognosis, and depletion of SIRT7can reprogram these cells to a less aggressive phenotype.